Design, synthesis, and anticonvulsant activity of some sulfamides. 2007

L Gavernet, and I A Barrios, and M Sella Cravero, and L E Bruno-Blanch
Medicinal Chemistry, Department of Biological Sciences, National University of La Plata, 47 and 115, La Plata B1900BJW, Argentina.

As part of our search for potential anticonvulsant agents, a set of compounds were designed, synthesized, and evaluated against MES and PTZ tests. Bioisosteric functional group information was used to design a new functionality, sulfamides, that complies with the requirements of the pharmacophore previously defined. Some of the molecules showed a promising anticonvulsant profile as selective anti-MES drugs, being active at low concentrations (30mg/kg). The biological data were confirmed in Phase II of the Anticonvulsant Drug Development Program of the National Institute of Health.

UI MeSH Term Description Entries
D008297 Male Males
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D004583 Electrons Stable elementary particles having the smallest known negative charge, present in all elements; also called negatrons. Positively charged electrons are called positrons. The numbers, energies and arrangement of electrons around atomic nuclei determine the chemical identities of elements. Beams of electrons are called CATHODE RAYS. Fast Electrons,Negatrons,Positrons,Electron,Electron, Fast,Electrons, Fast,Fast Electron,Negatron,Positron
D000577 Amides Organic compounds containing the -CO-NH2 radical. Amides are derived from acids by replacement of -OH by -NH2 or from ammonia by the replacement of H by an acyl group. (From Grant & Hackh's Chemical Dictionary, 5th ed) Amide
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000927 Anticonvulsants Drugs used to prevent SEIZURES or reduce their severity. Anticonvulsant,Anticonvulsant Drug,Anticonvulsive Agent,Anticonvulsive Drug,Antiepileptic,Antiepileptic Agent,Antiepileptic Agents,Antiepileptic Drug,Anticonvulsant Drugs,Anticonvulsive Agents,Anticonvulsive Drugs,Antiepileptic Drugs,Antiepileptics,Agent, Anticonvulsive,Agent, Antiepileptic,Agents, Anticonvulsive,Agents, Antiepileptic,Drug, Anticonvulsant,Drug, Anticonvulsive,Drug, Antiepileptic,Drugs, Anticonvulsant,Drugs, Anticonvulsive,Drugs, Antiepileptic
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013455 Sulfur An element that is a member of the chalcogen family. It has an atomic symbol S, atomic number 16, and atomic weight [32.059; 32.076]. It is found in the amino acids cysteine and methionine. Sulfur-16,Sulfur 16
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

L Gavernet, and I A Barrios, and M Sella Cravero, and L E Bruno-Blanch
March 2009, Journal of medicinal chemistry,
L Gavernet, and I A Barrios, and M Sella Cravero, and L E Bruno-Blanch
January 2013, EXCLI journal,
L Gavernet, and I A Barrios, and M Sella Cravero, and L E Bruno-Blanch
March 2017, Chemical biology & drug design,
L Gavernet, and I A Barrios, and M Sella Cravero, and L E Bruno-Blanch
January 2008, Current pharmaceutical design,
L Gavernet, and I A Barrios, and M Sella Cravero, and L E Bruno-Blanch
November 2004, Bollettino chimico farmaceutico,
L Gavernet, and I A Barrios, and M Sella Cravero, and L E Bruno-Blanch
February 1962, The Journal of pharmacy and pharmacology,
L Gavernet, and I A Barrios, and M Sella Cravero, and L E Bruno-Blanch
January 2010, Arzneimittel-Forschung,
L Gavernet, and I A Barrios, and M Sella Cravero, and L E Bruno-Blanch
September 1994, Chemical & pharmaceutical bulletin,
L Gavernet, and I A Barrios, and M Sella Cravero, and L E Bruno-Blanch
January 2012, Acta poloniae pharmaceutica,
L Gavernet, and I A Barrios, and M Sella Cravero, and L E Bruno-Blanch
July 2010, Archives of pharmacal research,
Copied contents to your clipboard!